Reports

Industry Research Reports

Global Adeno-Associated Virus (AAV) Packaging Service Market Research Report 2026

Global Adeno-Associated Virus (AAV) Packaging Service Market Research Report 2026

Industry: Medical Care

Published Date: 2026-07-18

Pages: 144 Pages

Report ld: 5588249

application for samples

Request Sample

Custom reports

Customized Report

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

Adeno-Associated Virus (AAV) Packaging Service Market Size(US$)

den_QYR1
cagr

CAGR 2026-2032

11.1%

marketSize

Market Size,2032

USD 2,627

Million

Market Snapshot

Market Size in 2026 (Value)
US$ 1,397 million
Market Forecast in 2032(Value)
US$ 2,627 million
CAGR
11.1%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Adeno-Associated Virus (AAV) Packaging Service market was valued at US$ 1249 million in 2025 and is anticipated to reach US$ 2627 million by 2032, at a CAGR of 11.1% from 2026 to 2032.

Adeno-associated virus (AAV) packaging services refer to customized development and manufacturing activities in which a customer-provided or jointly designed ITR-containing construct is packaged into a recombinant AAV vector carrying a gene of interest, gene-silencing sequence, gene-editing component or reporter gene. The service workflow generally includes vector design and construction, plasmid preparation, cell culture and transfection, vector harvest, purification, concentration, aliquoting and quality testing, covering research-grade, preclinical-grade and GMP-grade projects. Key upstream inputs include transfer plasmids, Rep/Cap plasmids, helper plasmids, HEK293 or Sf9 cells, culture media, transfection reagents, nucleases, chromatography resins, filtration consumables and analytical reagents. Major downstream customers include universities, research institutes, hospital research platforms, gene therapy developers, biotechnology companies, pharmaceutical companies and CROs, with applications spanning basic research, animal studies, preclinical evaluation, IND submissions, clinical development and commercial manufacturing. The industry's overall gross margin is generally estimated at approximately 32%-48%.

The global market consists of research-grade packaging providers, specialized AAV CROs, integrated cell and gene therapy CDMOs and large biopharmaceutical service groups operating dedicated AAV platforms. Research-grade projects are numerous, relatively short and fragmented, with competition centered on serotype coverage, titer, purity, turnaround time and price. Preclinical and GMP programs are less frequent but require considerably greater investment in process scale-up, analytical methods, batch consistency, quality systems and regulatory documentation. Providers capable of maintaining process continuity from vector design and small-scale packaging through GMP and commercial manufacturing generally develop stronger customer retention, particularly after a program enters clinical development.

Demand is supported by gene-function research, rare-disease and neurological gene therapy, engineered-capsid screening, gene-editing delivery and greater outsourcing by biotechnology companies. Different AAV capsids enable gene delivery to the eye, liver, central nervous system, muscle and other tissues, while dual- and multi-vector systems extend the technology to larger or more complex payloads. The FDA's 2026 approval of the first dual-AAV gene therapy for inherited hearing loss demonstrates the continued expansion of AAV into new vector configurations and therapeutic areas, supporting demand for dual-vector development, analytics and scalable manufacturing.

Adherent HEK293 triple-plasmid transfection remains widely used for research and smaller programs, while suspension HEK293 systems have become the principal route for clinical and commercial scale-up. Baculovirus-Sf9 systems are used in selected large-scale processes. Stable producer-cell lines, dual-plasmid systems and plasmid-reduced technologies are being developed to lower raw-material costs and improve consistency. Downstream competition is moving beyond vector-genome titer toward full-capsid enrichment, genome-integrity control and tighter reduction of host-cell proteins, residual DNA, residual plasmids and replication-competent AAV.

The principal constraints include gene therapy financing and pipeline reprioritization, high clinical attrition, underutilized GMP facilities, elevated manufacturing costs and the immunological and safety limitations of AAV. Serious liver-related safety events led the FDA to restrict the use of a major AAV gene therapy in 2025, increasing the focus on dose selection, impurity control, clinical monitoring and long-term follow-up. At the same time, the FDA introduced a more flexible approach to certain cell and gene therapy CMC requirements in 2026, which may help selected rare-disease programs progress more efficiently but does not reduce expectations for identity, potency, purity and manufacturing consistency.

This report delivers a comprehensive overview of the global Adeno-Associated Virus (AAV) Packaging Service market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Adeno-Associated Virus (AAV) Packaging Service. The Adeno-Associated Virus (AAV) Packaging Service market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Adeno-Associated Virus (AAV) Packaging Service market comprehensively. Regional market sizes by Type, by Application, by Service Scope, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Adeno-Associated Virus (AAV) Packaging Service manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

MARKET SEGMENTATION

By Company

  • Thermo Fisher Scientific
  • Lonza
  • Charles River Laboratories
  • Catalent
  • AGC Biologics
  • SK pharmteco
  • OXB
  • Forge Biologics
  • Viralgen
  • Andelyn Biosciences
  • Revvity
  • Virovek
  • Fortis Life Sciences
  • SignaGen Laboratories
  • Applied Biological Materials
  • Takara Bio
  • VectorBuilder
  • GenScript ProBio
  • PackGene Biotech
  • OBiO Technology
  • Porton Advanced
  • HanBio

Consumption by Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Segment by Type

  • Research Grade
  • Preclinical Grade
  • GMP Grade

Segment by Application

  • Academic and Research Institutions
  • Biotechnology Companies
  • Other

Segment by Category

  • Packaging Only
  • Vector Construction and Packaging
  • End-to-End Development and Manufacturing

Segment by Division

  • Adherent HEK293
  • Suspension HEK293
  • Baculovirus-Sf9
  • Other

biaoTi CHAPTER OUTLINE

marn_i1

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Service Scope, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.

marn_i1

Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.

marn_i1

Chapter 3: Provides a detailed view of the competitive landscape for Adeno-Associated Virus (AAV) Packaging Service companies, covering revenue share, development plans, and mergers and acquisitions.

marn_i1

Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.

marn_i1

Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.

marn_i1

Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.

marn_i1

Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.

marn_i1

Chapter 12: Key findings and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region
Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

den_ic6
Product mix optimization based on local practices
Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

den_ic6
Competitor tactics in fragmented vs. consolidated markets
Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

den_ic6
Full Research Coverage
Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

den_ic6
19 Years Industry Expertise
19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

den_ic6
24/7 Fast Report Delivery
24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

den_ic6
Localized Strategic Analysis
Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

den_ic6
den_biaoTiZhungShi

TABLE OF CONTENTS

muLu

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Adeno-Associated Virus (AAV) Packaging Service Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Research Grade

1.2.3 Preclinical Grade

1.2.4 GMP Grade

1.3 Market by Service Scope

1.3.1 Global Adeno-Associated Virus (AAV) Packaging Service Market Size Growth Rate by Service Scope: 2021 vs 2025 vs 2032

1.3.2 Packaging Only

1.3.3 Vector Construction and Packaging

1.3.4 End-to-End Development and Manufacturing

1.4 Market by Production Platform

1.4.1 Global Adeno-Associated Virus (AAV) Packaging Service Market Size Growth Rate by Production Platform: 2021 vs 2025 vs 2032

1.4.2 Adherent HEK293

1.4.3 Suspension HEK293

1.4.4 Baculovirus-Sf9

1.4.5 Other

1.5 Market by Application

1.5.1 Global Adeno-Associated Virus (AAV) Packaging Service Market Growth by Application: 2021 vs 2025 vs 2032

1.5.2 Academic and Research Institutions

1.5.3 Biotechnology Companies

1.5.4 Other

1.6 Assumptions and Limitations

1.7 Study Objectives

1.8 Years Considered

muLu

2 Global Growth Trends

2.1 Global Adeno-Associated Virus (AAV) Packaging Service Market Perspective (2021–2032)

2.2 Global Adeno-Associated Virus (AAV) Packaging Service Growth Trends by Region

2.2.1 Global Adeno-Associated Virus (AAV) Packaging Service Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Adeno-Associated Virus (AAV) Packaging Service Historic Market Size by Region (2021–2026)

2.2.3 Adeno-Associated Virus (AAV) Packaging Service Forecasted Market Size by Region (2027–2032)

2.3 Adeno-Associated Virus (AAV) Packaging Service Market Dynamics

2.3.1 Adeno-Associated Virus (AAV) Packaging Service Industry Trends

2.3.2 Adeno-Associated Virus (AAV) Packaging Service Market Drivers

2.3.3 Adeno-Associated Virus (AAV) Packaging Service Market Challenges

2.3.4 Adeno-Associated Virus (AAV) Packaging Service Market Restraints

muLu

3 Competition Landscape by Key Players

3.1 Global Top Adeno-Associated Virus (AAV) Packaging Service Players by Revenue

3.1.1 Global Top Adeno-Associated Virus (AAV) Packaging Service Players by Revenue (2021–2026)

3.1.2 Global Adeno-Associated Virus (AAV) Packaging Service Revenue Market Share by Players (2021–2026)

3.2 Global Top Adeno-Associated Virus (AAV) Packaging Service Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Adeno-Associated Virus (AAV) Packaging Service Revenue

3.4 Global Adeno-Associated Virus (AAV) Packaging Service Market Concentration Ratio

3.4.1 Global Adeno-Associated Virus (AAV) Packaging Service Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Adeno-Associated Virus (AAV) Packaging Service Revenue in 2025

3.5 Global Key Players of Adeno-Associated Virus (AAV) Packaging Service Head Offices and Areas Served

3.6 Global Key Players of Adeno-Associated Virus (AAV) Packaging Service, Products and Applications

3.7 Global Key Players of Adeno-Associated Virus (AAV) Packaging Service, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

muLu

4 Adeno-Associated Virus (AAV) Packaging Service Breakdown Data by Type

4.1 Global Adeno-Associated Virus (AAV) Packaging Service Historic Market Size by Type (2021–2026)

4.2 Global Adeno-Associated Virus (AAV) Packaging Service Forecasted Market Size by Type (2027–2032)

muLu

5 Adeno-Associated Virus (AAV) Packaging Service Breakdown Data by Application

5.1 Global Adeno-Associated Virus (AAV) Packaging Service Historic Market Size by Application (2021–2026)

5.2 Global Adeno-Associated Virus (AAV) Packaging Service Forecasted Market Size by Application (2027–2032)

muLu

6 North America

6.1 North America Adeno-Associated Virus (AAV) Packaging Service Market Size (2021–2032)

6.2 North America Adeno-Associated Virus (AAV) Packaging Service Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Adeno-Associated Virus (AAV) Packaging Service Market Size by Country (2021–2026)

6.4 North America Adeno-Associated Virus (AAV) Packaging Service Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

muLu

7 Europe

7.1 Europe Adeno-Associated Virus (AAV) Packaging Service Market Size (2021–2032)

7.2 Europe Adeno-Associated Virus (AAV) Packaging Service Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Adeno-Associated Virus (AAV) Packaging Service Market Size by Country (2021–2026)

7.4 Europe Adeno-Associated Virus (AAV) Packaging Service Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

muLu

8 Asia-Pacific

8.1 Asia-Pacific Adeno-Associated Virus (AAV) Packaging Service Market Size (2021–2032)

8.2 Asia-Pacific Adeno-Associated Virus (AAV) Packaging Service Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Adeno-Associated Virus (AAV) Packaging Service Market Size by Region (2021–2026)

8.4 Asia-Pacific Adeno-Associated Virus (AAV) Packaging Service Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

muLu

9 Latin America

9.1 Latin America Adeno-Associated Virus (AAV) Packaging Service Market Size (2021–2032)

9.2 Latin America Adeno-Associated Virus (AAV) Packaging Service Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Adeno-Associated Virus (AAV) Packaging Service Market Size by Country (2021–2026)

9.4 Latin America Adeno-Associated Virus (AAV) Packaging Service Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

muLu

10 Middle East & Africa

10.1 Middle East & Africa Adeno-Associated Virus (AAV) Packaging Service Market Size (2021–2032)

10.2 Middle East & Africa Adeno-Associated Virus (AAV) Packaging Service Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Adeno-Associated Virus (AAV) Packaging Service Market Size by Country (2021–2026)

10.4 Middle East & Africa Adeno-Associated Virus (AAV) Packaging Service Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

muLu

11 Key Players Profiles

11.1 Thermo Fisher Scientific

11.1.1 Thermo Fisher Scientific Company Details

11.1.2 Thermo Fisher Scientific Business Overview

11.1.3 Thermo Fisher Scientific Adeno-Associated Virus (AAV) Packaging Service Introduction

11.1.4 Thermo Fisher Scientific Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021–2026)

11.1.5 Thermo Fisher Scientific Recent Development

11.2 Lonza

11.2.1 Lonza Company Details

11.2.2 Lonza Business Overview

11.2.3 Lonza Adeno-Associated Virus (AAV) Packaging Service Introduction

11.2.4 Lonza Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021–2026)

11.2.5 Lonza Recent Development

11.3 Charles River Laboratories

11.3.1 Charles River Laboratories Company Details

11.3.2 Charles River Laboratories Business Overview

11.3.3 Charles River Laboratories Adeno-Associated Virus (AAV) Packaging Service Introduction

11.3.4 Charles River Laboratories Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021–2026)

11.3.5 Charles River Laboratories Recent Development

11.4 Catalent

11.4.1 Catalent Company Details

11.4.2 Catalent Business Overview

11.4.3 Catalent Adeno-Associated Virus (AAV) Packaging Service Introduction

11.4.4 Catalent Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021–2026)

11.4.5 Catalent Recent Development

11.5 AGC Biologics

11.5.1 AGC Biologics Company Details

11.5.2 AGC Biologics Business Overview

11.5.3 AGC Biologics Adeno-Associated Virus (AAV) Packaging Service Introduction

11.5.4 AGC Biologics Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021–2026)

11.5.5 AGC Biologics Recent Development

11.6 SK pharmteco

11.6.1 SK pharmteco Company Details

11.6.2 SK pharmteco Business Overview

11.6.3 SK pharmteco Adeno-Associated Virus (AAV) Packaging Service Introduction

11.6.4 SK pharmteco Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021–2026)

11.6.5 SK pharmteco Recent Development

11.7 OXB

11.7.1 OXB Company Details

11.7.2 OXB Business Overview

11.7.3 OXB Adeno-Associated Virus (AAV) Packaging Service Introduction

11.7.4 OXB Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021–2026)

11.7.5 OXB Recent Development

11.8 Forge Biologics

11.8.1 Forge Biologics Company Details

11.8.2 Forge Biologics Business Overview

11.8.3 Forge Biologics Adeno-Associated Virus (AAV) Packaging Service Introduction

11.8.4 Forge Biologics Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021–2026)

11.8.5 Forge Biologics Recent Development

11.9 Viralgen

11.9.1 Viralgen Company Details

11.9.2 Viralgen Business Overview

11.9.3 Viralgen Adeno-Associated Virus (AAV) Packaging Service Introduction

11.9.4 Viralgen Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021–2026)

11.9.5 Viralgen Recent Development

11.10 Andelyn Biosciences

11.10.1 Andelyn Biosciences Company Details

11.10.2 Andelyn Biosciences Business Overview

11.10.3 Andelyn Biosciences Adeno-Associated Virus (AAV) Packaging Service Introduction

11.10.4 Andelyn Biosciences Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021–2026)

11.10.5 Andelyn Biosciences Recent Development

11.11 Revvity

11.11.1 Revvity Company Details

11.11.2 Revvity Business Overview

11.11.3 Revvity Adeno-Associated Virus (AAV) Packaging Service Introduction

11.11.4 Revvity Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021–2026)

11.11.5 Revvity Recent Development

11.12 Virovek

11.12.1 Virovek Company Details

11.12.2 Virovek Business Overview

11.12.3 Virovek Adeno-Associated Virus (AAV) Packaging Service Introduction

11.12.4 Virovek Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021–2026)

11.12.5 Virovek Recent Development

11.13 Fortis Life Sciences

11.13.1 Fortis Life Sciences Company Details

11.13.2 Fortis Life Sciences Business Overview

11.13.3 Fortis Life Sciences Adeno-Associated Virus (AAV) Packaging Service Introduction

11.13.4 Fortis Life Sciences Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021–2026)

11.13.5 Fortis Life Sciences Recent Development

11.14 SignaGen Laboratories

11.14.1 SignaGen Laboratories Company Details

11.14.2 SignaGen Laboratories Business Overview

11.14.3 SignaGen Laboratories Adeno-Associated Virus (AAV) Packaging Service Introduction

11.14.4 SignaGen Laboratories Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021–2026)

11.14.5 SignaGen Laboratories Recent Development

11.15 Applied Biological Materials

11.15.1 Applied Biological Materials Company Details

11.15.2 Applied Biological Materials Business Overview

11.15.3 Applied Biological Materials Adeno-Associated Virus (AAV) Packaging Service Introduction

11.15.4 Applied Biological Materials Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021–2026)

11.15.5 Applied Biological Materials Recent Development

11.16 Takara Bio

11.16.1 Takara Bio Company Details

11.16.2 Takara Bio Business Overview

11.16.3 Takara Bio Adeno-Associated Virus (AAV) Packaging Service Introduction

11.16.4 Takara Bio Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021–2026)

11.16.5 Takara Bio Recent Development

11.17 VectorBuilder

11.17.1 VectorBuilder Company Details

11.17.2 VectorBuilder Business Overview

11.17.3 VectorBuilder Adeno-Associated Virus (AAV) Packaging Service Introduction

11.17.4 VectorBuilder Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021–2026)

11.17.5 VectorBuilder Recent Development

11.18 GenScript ProBio

11.18.1 GenScript ProBio Company Details

11.18.2 GenScript ProBio Business Overview

11.18.3 GenScript ProBio Adeno-Associated Virus (AAV) Packaging Service Introduction

11.18.4 GenScript ProBio Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021–2026)

11.18.5 GenScript ProBio Recent Development

11.19 PackGene Biotech

11.19.1 PackGene Biotech Company Details

11.19.2 PackGene Biotech Business Overview

11.19.3 PackGene Biotech Adeno-Associated Virus (AAV) Packaging Service Introduction

11.19.4 PackGene Biotech Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021–2026)

11.19.5 PackGene Biotech Recent Development

11.20 OBiO Technology

11.20.1 OBiO Technology Company Details

11.20.2 OBiO Technology Business Overview

11.20.3 OBiO Technology Adeno-Associated Virus (AAV) Packaging Service Introduction

11.20.4 OBiO Technology Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021–2026)

11.20.5 OBiO Technology Recent Development

11.21 Porton Advanced

11.21.1 Porton Advanced Company Details

11.21.2 Porton Advanced Business Overview

11.21.3 Porton Advanced Adeno-Associated Virus (AAV) Packaging Service Introduction

11.21.4 Porton Advanced Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021–2026)

11.21.5 Porton Advanced Recent Development

11.22 HanBio

11.22.1 HanBio Company Details

11.22.2 HanBio Business Overview

11.22.3 HanBio Adeno-Associated Virus (AAV) Packaging Service Introduction

11.22.4 HanBio Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (2021–2026)

11.22.5 HanBio Recent Development

muLu

12 Analyst's Viewpoints/Conclusions

muLu

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

den_biaoTiZhungShi

TABLE OF FIGURES

muLu

List of Tables

Table 1. Global Adeno-Associated Virus (AAV) Packaging Service Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Research Grade
Table 3. Key Players of Preclinical Grade
Table 4. Key Players of GMP Grade
Table 5. Global Adeno-Associated Virus (AAV) Packaging Service Market Size Growth Rate by Service Scope (US$ Million): 2021 vs 2025 vs 2032
Table 6. Key Players of Packaging Only
Table 7. Key Players of Vector Construction and Packaging
Table 8. Key Players of End-to-End Development and Manufacturing
Table 9. Global Adeno-Associated Virus (AAV) Packaging Service Market Size Growth Rate by Production Platform (US$ Million): 2021 vs 2025 vs 2032
Table 10. Key Players of Adherent HEK293
Table 11. Key Players of Suspension HEK293
Table 12. Key Players of Baculovirus-Sf9
Table 13. Key Players of Other
Table 14. Global Adeno-Associated Virus (AAV) Packaging Service Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 15. Global Adeno-Associated Virus (AAV) Packaging Service Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 16. Global Adeno-Associated Virus (AAV) Packaging Service Market Size by Region (US$ Million), 2021–2026
Table 17. Global Adeno-Associated Virus (AAV) Packaging Service Market Share by Region (2021–2026)
Table 18. Global Adeno-Associated Virus (AAV) Packaging Service Forecasted Market Size by Region (US$ Million), 2027–2032
Table 19. Global Adeno-Associated Virus (AAV) Packaging Service Market Share by Region (2027–2032)
Table 20. Adeno-Associated Virus (AAV) Packaging Service Market Trends
Table 21. Adeno-Associated Virus (AAV) Packaging Service Market Drivers
Table 22. Adeno-Associated Virus (AAV) Packaging Service Market Challenges
Table 23. Adeno-Associated Virus (AAV) Packaging Service Market Restraints
Table 24. Global Adeno-Associated Virus (AAV) Packaging Service Revenue by Players (US$ Million), 2021–2026
Table 25. Global Adeno-Associated Virus (AAV) Packaging Service Market Share by Players (2021–2026)
Table 26. Global Top Adeno-Associated Virus (AAV) Packaging Service Players by Tier (Tier 1, Tier 2, and Tier 3), based on Adeno-Associated Virus (AAV) Packaging Service Revenue, 2025
Table 27. Ranking of Global Top Adeno-Associated Virus (AAV) Packaging Service Companies by Revenue (US$ Million) in 2025
Table 28. Global 5 Largest Players Market Share by Adeno-Associated Virus (AAV) Packaging Service Revenue (CR5 and HHI), 2021–2026
Table 29. Global Key Players of Adeno-Associated Virus (AAV) Packaging Service, Headquarters and Area Served
Table 30. Global Key Players of Adeno-Associated Virus (AAV) Packaging Service, Products and Applications
Table 31. Global Key Players of Adeno-Associated Virus (AAV) Packaging Service, Date of General Availability (GA)
Table 32. Mergers and Acquisitions, Expansion Plans
Table 33. Global Adeno-Associated Virus (AAV) Packaging Service Market Size by Type (US$ Million), 2021–2026
Table 34. Global Adeno-Associated Virus (AAV) Packaging Service Revenue Market Share by Type (2021–2026)
Table 35. Global Adeno-Associated Virus (AAV) Packaging Service Forecasted Market Size by Type (US$ Million), 2027–2032
Table 36. Global Adeno-Associated Virus (AAV) Packaging Service Revenue Market Share by Type (2027–2032)
Table 37. Global Adeno-Associated Virus (AAV) Packaging Service Market Size by Application (US$ Million), 2021–2026
Table 38. Global Adeno-Associated Virus (AAV) Packaging Service Revenue Market Share by Application (2021–2026)
Table 39. Global Adeno-Associated Virus (AAV) Packaging Service Forecasted Market Size by Application (US$ Million), 2027–2032
Table 40. Global Adeno-Associated Virus (AAV) Packaging Service Revenue Market Share by Application (2027–2032)
Table 41. North America Adeno-Associated Virus (AAV) Packaging Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 42. North America Adeno-Associated Virus (AAV) Packaging Service Market Size by Country (US$ Million), 2021–2026
Table 43. North America Adeno-Associated Virus (AAV) Packaging Service Market Size by Country (US$ Million), 2027–2032
Table 44. Europe Adeno-Associated Virus (AAV) Packaging Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 45. Europe Adeno-Associated Virus (AAV) Packaging Service Market Size by Country (US$ Million), 2021–2026
Table 46. Europe Adeno-Associated Virus (AAV) Packaging Service Market Size by Country (US$ Million), 2027–2032
Table 47. Asia-Pacific Adeno-Associated Virus (AAV) Packaging Service Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 48. Asia-Pacific Adeno-Associated Virus (AAV) Packaging Service Market Size by Region (US$ Million), 2021–2026
Table 49. Asia-Pacific Adeno-Associated Virus (AAV) Packaging Service Market Size by Region (US$ Million), 2027–2032
Table 50. Latin America Adeno-Associated Virus (AAV) Packaging Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 51. Latin America Adeno-Associated Virus (AAV) Packaging Service Market Size by Country (US$ Million), 2021–2026
Table 52. Latin America Adeno-Associated Virus (AAV) Packaging Service Market Size by Country (US$ Million), 2027–2032
Table 53. Middle East & Africa Adeno-Associated Virus (AAV) Packaging Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 54. Middle East & Africa Adeno-Associated Virus (AAV) Packaging Service Market Size by Country (US$ Million), 2021–2026
Table 55. Middle East & Africa Adeno-Associated Virus (AAV) Packaging Service Market Size by Country (US$ Million), 2027–2032
Table 56. Thermo Fisher Scientific Company Details
Table 57. Thermo Fisher Scientific Business Overview
Table 58. Thermo Fisher Scientific Adeno-Associated Virus (AAV) Packaging Service Product
Table 59. Thermo Fisher Scientific Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (US$ Million), 2021–2026
Table 60. Thermo Fisher Scientific Recent Development
Table 61. Lonza Company Details
Table 62. Lonza Business Overview
Table 63. Lonza Adeno-Associated Virus (AAV) Packaging Service Product
Table 64. Lonza Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (US$ Million), 2021–2026
Table 65. Lonza Recent Development
Table 66. Charles River Laboratories Company Details
Table 67. Charles River Laboratories Business Overview
Table 68. Charles River Laboratories Adeno-Associated Virus (AAV) Packaging Service Product
Table 69. Charles River Laboratories Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (US$ Million), 2021–2026
Table 70. Charles River Laboratories Recent Development
Table 71. Catalent Company Details
Table 72. Catalent Business Overview
Table 73. Catalent Adeno-Associated Virus (AAV) Packaging Service Product
Table 74. Catalent Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (US$ Million), 2021–2026
Table 75. Catalent Recent Development
Table 76. AGC Biologics Company Details
Table 77. AGC Biologics Business Overview
Table 78. AGC Biologics Adeno-Associated Virus (AAV) Packaging Service Product
Table 79. AGC Biologics Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (US$ Million), 2021–2026
Table 80. AGC Biologics Recent Development
Table 81. SK pharmteco Company Details
Table 82. SK pharmteco Business Overview
Table 83. SK pharmteco Adeno-Associated Virus (AAV) Packaging Service Product
Table 84. SK pharmteco Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (US$ Million), 2021–2026
Table 85. SK pharmteco Recent Development
Table 86. OXB Company Details
Table 87. OXB Business Overview
Table 88. OXB Adeno-Associated Virus (AAV) Packaging Service Product
Table 89. OXB Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (US$ Million), 2021–2026
Table 90. OXB Recent Development
Table 91. Forge Biologics Company Details
Table 92. Forge Biologics Business Overview
Table 93. Forge Biologics Adeno-Associated Virus (AAV) Packaging Service Product
Table 94. Forge Biologics Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (US$ Million), 2021–2026
Table 95. Forge Biologics Recent Development
Table 96. Viralgen Company Details
Table 97. Viralgen Business Overview
Table 98. Viralgen Adeno-Associated Virus (AAV) Packaging Service Product
Table 99. Viralgen Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (US$ Million), 2021–2026
Table 100. Viralgen Recent Development
Table 101. Andelyn Biosciences Company Details
Table 102. Andelyn Biosciences Business Overview
Table 103. Andelyn Biosciences Adeno-Associated Virus (AAV) Packaging Service Product
Table 104. Andelyn Biosciences Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (US$ Million), 2021–2026
Table 105. Andelyn Biosciences Recent Development
Table 106. Revvity Company Details
Table 107. Revvity Business Overview
Table 108. Revvity Adeno-Associated Virus (AAV) Packaging Service Product
Table 109. Revvity Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (US$ Million), 2021–2026
Table 110. Revvity Recent Development
Table 111. Virovek Company Details
Table 112. Virovek Business Overview
Table 113. Virovek Adeno-Associated Virus (AAV) Packaging Service Product
Table 114. Virovek Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (US$ Million), 2021–2026
Table 115. Virovek Recent Development
Table 116. Fortis Life Sciences Company Details
Table 117. Fortis Life Sciences Business Overview
Table 118. Fortis Life Sciences Adeno-Associated Virus (AAV) Packaging Service Product
Table 119. Fortis Life Sciences Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (US$ Million), 2021–2026
Table 120. Fortis Life Sciences Recent Development
Table 121. SignaGen Laboratories Company Details
Table 122. SignaGen Laboratories Business Overview
Table 123. SignaGen Laboratories Adeno-Associated Virus (AAV) Packaging Service Product
Table 124. SignaGen Laboratories Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (US$ Million), 2021–2026
Table 125. SignaGen Laboratories Recent Development
Table 126. Applied Biological Materials Company Details
Table 127. Applied Biological Materials Business Overview
Table 128. Applied Biological Materials Adeno-Associated Virus (AAV) Packaging Service Product
Table 129. Applied Biological Materials Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (US$ Million), 2021–2026
Table 130. Applied Biological Materials Recent Development
Table 131. Takara Bio Company Details
Table 132. Takara Bio Business Overview
Table 133. Takara Bio Adeno-Associated Virus (AAV) Packaging Service Product
Table 134. Takara Bio Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (US$ Million), 2021–2026
Table 135. Takara Bio Recent Development
Table 136. VectorBuilder Company Details
Table 137. VectorBuilder Business Overview
Table 138. VectorBuilder Adeno-Associated Virus (AAV) Packaging Service Product
Table 139. VectorBuilder Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (US$ Million), 2021–2026
Table 140. VectorBuilder Recent Development
Table 141. GenScript ProBio Company Details
Table 142. GenScript ProBio Business Overview
Table 143. GenScript ProBio Adeno-Associated Virus (AAV) Packaging Service Product
Table 144. GenScript ProBio Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (US$ Million), 2021–2026
Table 145. GenScript ProBio Recent Development
Table 146. PackGene Biotech Company Details
Table 147. PackGene Biotech Business Overview
Table 148. PackGene Biotech Adeno-Associated Virus (AAV) Packaging Service Product
Table 149. PackGene Biotech Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (US$ Million), 2021–2026
Table 150. PackGene Biotech Recent Development
Table 151. OBiO Technology Company Details
Table 152. OBiO Technology Business Overview
Table 153. OBiO Technology Adeno-Associated Virus (AAV) Packaging Service Product
Table 154. OBiO Technology Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (US$ Million), 2021–2026
Table 155. OBiO Technology Recent Development
Table 156. Porton Advanced Company Details
Table 157. Porton Advanced Business Overview
Table 158. Porton Advanced Adeno-Associated Virus (AAV) Packaging Service Product
Table 159. Porton Advanced Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (US$ Million), 2021–2026
Table 160. Porton Advanced Recent Development
Table 161. HanBio Company Details
Table 162. HanBio Business Overview
Table 163. HanBio Adeno-Associated Virus (AAV) Packaging Service Product
Table 164. HanBio Revenue in Adeno-Associated Virus (AAV) Packaging Service Business (US$ Million), 2021–2026
Table 165. HanBio Recent Development
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
Table 169. Authors List of This Report
muLu

List of Figures

Figure 1. Adeno-Associated Virus (AAV) Packaging Service Picture
Figure 2. Global Adeno-Associated Virus (AAV) Packaging Service Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Adeno-Associated Virus (AAV) Packaging Service Market Share by Type: 2025 vs 2032
Figure 4. Research Grade Features
Figure 5. Preclinical Grade Features
Figure 6. GMP Grade Features
Figure 7. Global Adeno-Associated Virus (AAV) Packaging Service Market Size Comparison by Service Scope (US$ Million), 2021–2032
Figure 8. Packaging Only Features
Figure 9. Vector Construction and Packaging Features
Figure 10. End-to-End Development and Manufacturing Features
Figure 11. Global Adeno-Associated Virus (AAV) Packaging Service Market Size Comparison by Production Platform (US$ Million), 2021–2032
Figure 12. Adherent HEK293 Features
Figure 13. Suspension HEK293 Features
Figure 14. Baculovirus-Sf9 Features
Figure 15. Other Features
Figure 16. Global Adeno-Associated Virus (AAV) Packaging Service Market Size by Application (US$ Million), 2021–2032
Figure 17. Global Adeno-Associated Virus (AAV) Packaging Service Market Share by Application: 2025 vs 2032
Figure 18. Academic and Research Institutions Case Studies
Figure 19. Biotechnology Companies Case Studies
Figure 20. Other Case Studies
Figure 21. Adeno-Associated Virus (AAV) Packaging Service Report Years Considered
Figure 22. Global Adeno-Associated Virus (AAV) Packaging Service Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 23. Global Adeno-Associated Virus (AAV) Packaging Service Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 24. Global Adeno-Associated Virus (AAV) Packaging Service Market Share by Region: 2025 vs 2032
Figure 25. Global Adeno-Associated Virus (AAV) Packaging Service Market Share by Players in 2025
Figure 26. Global Adeno-Associated Virus (AAV) Packaging Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 27. The Top 10 and 5 Players Market Share by Adeno-Associated Virus (AAV) Packaging Service Revenue in 2025
Figure 28. North America Adeno-Associated Virus (AAV) Packaging Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. North America Adeno-Associated Virus (AAV) Packaging Service Market Share by Country (2021–2032)
Figure 30. United States Adeno-Associated Virus (AAV) Packaging Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Canada Adeno-Associated Virus (AAV) Packaging Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Europe Adeno-Associated Virus (AAV) Packaging Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Europe Adeno-Associated Virus (AAV) Packaging Service Market Share by Country (2021–2032)
Figure 34. Germany Adeno-Associated Virus (AAV) Packaging Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. France Adeno-Associated Virus (AAV) Packaging Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. U.K. Adeno-Associated Virus (AAV) Packaging Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Italy Adeno-Associated Virus (AAV) Packaging Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Russia Adeno-Associated Virus (AAV) Packaging Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Ireland Adeno-Associated Virus (AAV) Packaging Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Asia-Pacific Adeno-Associated Virus (AAV) Packaging Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Asia-Pacific Adeno-Associated Virus (AAV) Packaging Service Market Share by Region (2021–2032)
Figure 42. China Adeno-Associated Virus (AAV) Packaging Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Japan Adeno-Associated Virus (AAV) Packaging Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. South Korea Adeno-Associated Virus (AAV) Packaging Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Southeast Asia Adeno-Associated Virus (AAV) Packaging Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. India Adeno-Associated Virus (AAV) Packaging Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Australia & New Zealand Adeno-Associated Virus (AAV) Packaging Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Latin America Adeno-Associated Virus (AAV) Packaging Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. Latin America Adeno-Associated Virus (AAV) Packaging Service Market Share by Country (2021–2032)
Figure 50. Mexico Adeno-Associated Virus (AAV) Packaging Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 51. Brazil Adeno-Associated Virus (AAV) Packaging Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 52. Middle East & Africa Adeno-Associated Virus (AAV) Packaging Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 53. Middle East & Africa Adeno-Associated Virus (AAV) Packaging Service Market Share by Country (2021–2032)
Figure 54. Israel Adeno-Associated Virus (AAV) Packaging Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 55. Saudi Arabia Adeno-Associated Virus (AAV) Packaging Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 56. UAE Adeno-Associated Virus (AAV) Packaging Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 57. Thermo Fisher Scientific Revenue Growth Rate in Adeno-Associated Virus (AAV) Packaging Service Business (2021–2026)
Figure 58. Lonza Revenue Growth Rate in Adeno-Associated Virus (AAV) Packaging Service Business (2021–2026)
Figure 59. Charles River Laboratories Revenue Growth Rate in Adeno-Associated Virus (AAV) Packaging Service Business (2021–2026)
Figure 60. Catalent Revenue Growth Rate in Adeno-Associated Virus (AAV) Packaging Service Business (2021–2026)
Figure 61. AGC Biologics Revenue Growth Rate in Adeno-Associated Virus (AAV) Packaging Service Business (2021–2026)
Figure 62. SK pharmteco Revenue Growth Rate in Adeno-Associated Virus (AAV) Packaging Service Business (2021–2026)
Figure 63. OXB Revenue Growth Rate in Adeno-Associated Virus (AAV) Packaging Service Business (2021–2026)
Figure 64. Forge Biologics Revenue Growth Rate in Adeno-Associated Virus (AAV) Packaging Service Business (2021–2026)
Figure 65. Viralgen Revenue Growth Rate in Adeno-Associated Virus (AAV) Packaging Service Business (2021–2026)
Figure 66. Andelyn Biosciences Revenue Growth Rate in Adeno-Associated Virus (AAV) Packaging Service Business (2021–2026)
Figure 67. Revvity Revenue Growth Rate in Adeno-Associated Virus (AAV) Packaging Service Business (2021–2026)
Figure 68. Virovek Revenue Growth Rate in Adeno-Associated Virus (AAV) Packaging Service Business (2021–2026)
Figure 69. Fortis Life Sciences Revenue Growth Rate in Adeno-Associated Virus (AAV) Packaging Service Business (2021–2026)
Figure 70. SignaGen Laboratories Revenue Growth Rate in Adeno-Associated Virus (AAV) Packaging Service Business (2021–2026)
Figure 71. Applied Biological Materials Revenue Growth Rate in Adeno-Associated Virus (AAV) Packaging Service Business (2021–2026)
Figure 72. Takara Bio Revenue Growth Rate in Adeno-Associated Virus (AAV) Packaging Service Business (2021–2026)
Figure 73. VectorBuilder Revenue Growth Rate in Adeno-Associated Virus (AAV) Packaging Service Business (2021–2026)
Figure 74. GenScript ProBio Revenue Growth Rate in Adeno-Associated Virus (AAV) Packaging Service Business (2021–2026)
Figure 75. PackGene Biotech Revenue Growth Rate in Adeno-Associated Virus (AAV) Packaging Service Business (2021–2026)
Figure 76. OBiO Technology Revenue Growth Rate in Adeno-Associated Virus (AAV) Packaging Service Business (2021–2026)
Figure 77. Porton Advanced Revenue Growth Rate in Adeno-Associated Virus (AAV) Packaging Service Business (2021–2026)
Figure 78. HanBio Revenue Growth Rate in Adeno-Associated Virus (AAV) Packaging Service Business (2021–2026)
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed
den_biaoTiZhungShi

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Adeno-Associated Virus (AAV) Packaging Service in 2026?zhanKai
The global market size of Adeno-Associated Virus (AAV) Packaging Service in 2026 was 1397 Million USD.
What is the annual compound growth rate of the global Adeno-Associated Virus (AAV) Packaging Service market size from 2026 to 2032?shouQi
Which region is expected to have the highest market share?shouQi
What was the global market size of Adeno-Associated Virus (AAV) Packaging Service in 2032?shouQi
Which companies rank high in the global Adeno-Associated Virus (AAV) Packaging Service market?shouQi
den_biaoTiZhungShi

Related Reports

Global Adeno-Associated Virus (AAV) Packaging Service Market Research Report 2026

Industry: Medical Care

Published Date: 2026-07-18

Pages: 144 Pages

Report ld: 5588249

CHOOSE LICENSE TYPE
tip

USD 2900.00

tip

USD 4350.00

tip

USD 5800.00

Add to Cart

Add to Cart

Buy Now

Buy Now

HAVE A QUESTION?
SIMON LEE

English,Chinese

Online

HITESH

English, Hindi

Offline

TANG XIN

Japanese,English

Offline

SUNG-BIN YOON

SUNG-BIN YOON

+82-2883 1278

Korean, English

Offline

YUJIE TIAN

Chinese, English

Offline

DAMON

Chinese, English

Offline

General Email:

REPORT COVERAGE

den_ic8

DESCRIPTION

zhankai
den_ic7

MARKET SEGMENTATION

den_ic7

QYRESEARCH'S STRENGTHS

den_ic8

TABLE OF CONTENTS

den_ic8

TABLE OF FIGURES

den_ic8

RLEATED REPORTS

INTEREST IN THIS REPORT?

yangBenGet A Free Sample

baoJia Request For Quotation

OR

NEED A CUSTOMIZED REPORT?

DingZhiCustomized Report

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now